These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 10552124)
21. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma. Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714 [TBL] [Abstract][Full Text] [Related]
22. [Expression of ASPP gene family and its relationship with survival of patients with non-small cell lung cancer]. Su M; Gu Y; Su S; Lu B Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):268-72. PubMed ID: 24989912 [TBL] [Abstract][Full Text] [Related]
23. p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosis. Pappot H; Francis D; Brünner N; Grondahl-Hansen J; Osterlind K Clin Cancer Res; 1996 Jan; 2(1):155-60. PubMed ID: 9816102 [TBL] [Abstract][Full Text] [Related]
24. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301 [TBL] [Abstract][Full Text] [Related]
25. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma. Diez M; Pollan M; Müguerza JM; Gaspar MJ; Duce AM; Alvarez MJ; Ratia T; Herñandez P; Ruiz A; Granell J Cancer; 2000 Jan; 88(1):35-41. PubMed ID: 10618603 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer. Fujino M; Dosaka-Akita H; Harada M; Hiroumi H; Kinoshita I; Akie K; Kawakami Y Cancer; 1995 Dec; 76(12):2457-63. PubMed ID: 8625071 [TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846 [TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of expression of p53 oncoprotein in primary (stage I-IIIa) non-small cell lung cancer. Tan DF; Li Q; Rammath N; Beck A; Wiseman S; Anderson T; al-Salameh A; Brooks J; Bepler G Anticancer Res; 2003; 23(2C):1665-72. PubMed ID: 12820438 [TBL] [Abstract][Full Text] [Related]
29. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection. Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851 [TBL] [Abstract][Full Text] [Related]
30. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery. Xu X; Sun PL; Li JZ; Jheon S; Lee CT; Chung JH J Thorac Oncol; 2011 Apr; 6(4):716-24. PubMed ID: 21336184 [TBL] [Abstract][Full Text] [Related]
31. Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer. Kumagai S; Marumo S; Arita M; Yamanashi K; Sumitomo R; Otake Y; Shoji T; Fukui M; Katayama T; Okumura N; Huang CL BMC Pulm Med; 2017 Dec; 17(1):166. PubMed ID: 29202834 [TBL] [Abstract][Full Text] [Related]
32. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer. Cao X; Chen YZ; Luo RZ; Zhang L; Zhang SL; Zeng J; Jiang YC; Han YJ; Wen ZS Oncotarget; 2015 May; 6(13):11704-13. PubMed ID: 25868976 [TBL] [Abstract][Full Text] [Related]
33. MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation. Higashiyama M; Doi O; Kodama K; Yokouchi H; Kasugai T; Ishiguro S; Takami K; Nakayama T; Nishisho I Br J Cancer; 1997; 75(9):1302-8. PubMed ID: 9155050 [TBL] [Abstract][Full Text] [Related]
34. Endothelial markers and circulating angiogenic factors and p53 may be potential markers for recurrence in surgically resected non-small cell lung cancer patients. Brattström D; Bergqvist M; Wester K; Hesselius P; Ren ZP; Scheibenpflug L; Wagenius G; Brodin O Med Sci Monit; 2004 Sep; 10(9):BR331-8. PubMed ID: 15328478 [TBL] [Abstract][Full Text] [Related]
35. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma. Dalquen P; Sauter G; Torhorst J; Schultheiss E; Jordan P; Lehmann S; Solèr M; Stulz P; Mihatsch MJ; Gudat F J Pathol; 1996 Jan; 178(1):53-8. PubMed ID: 8778317 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC). Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E J Cancer Res Clin Oncol; 2005 Jul; 131(7):479-85. PubMed ID: 15809880 [TBL] [Abstract][Full Text] [Related]
37. [Prognostic value of combined expression of Aurora A, p53 and p21 WAF1 in patients after curative resection of non-small cell lung cancer]. Li X; Liu N; Ren P; Cao Q; Wang P; Zhao L; Lu B; Wang P Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):512-6. PubMed ID: 26463327 [TBL] [Abstract][Full Text] [Related]
38. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer. Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907 [TBL] [Abstract][Full Text] [Related]
39. Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients. Harpole DH; Marks JR; Richards WG; Herndon JE; Sugarbaker DJ Clin Cancer Res; 1995 Jun; 1(6):659-64. PubMed ID: 9816029 [TBL] [Abstract][Full Text] [Related]
40. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients. Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]